Ancient Remedy for a Modern Disease: Will Celastrol Become a Treatment for Aortic Valve Stenosis?

Eitemau Tebyg

• Lipoprotein(a) and Oxidized Phospholipids in Calcific Aortic Valve Stenosis
  gan: Yeang, Calvin, et al.
  Cyhoeddwyd: (2016)
• Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial
  gan: Capoulade, Romain, et al.
  Cyhoeddwyd: (2018)
• Lipoprotein(a)-Associated Molecules Are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis
  gan: Torzewski, Michael, et al.
  Cyhoeddwyd: (2017)
• Potential causality and emerging medical therapies for lipoprotein(a) and its associated oxidized phospholipids in calcific aortic valve stenosis
  gan: Tsimikas, Sotirios
  Cyhoeddwyd: (2019)
• New Therapeutic Targets for Calcific Aortic Valve Stenosis: The Lipoprotein(a)-Lipoprotein-Associated Phospholipase A(2)-Oxidized Phospholipid Axis()
  gan: Hung, Ming-Yow, et al.
  Cyhoeddwyd: (2013)